metastatic tumors

Related by string. metastatic tumor * Metastatic : metastatic prostate cancer . IV metastatic melanoma . metastatic pancreatic cancer . metastatic lesions . metastatic melanoma . metastatic colorectal cancer / Tumor . Tumors . TUMOR . TUMORS : malignant brain tumor . cancerous brain tumor . battling brain tumor . brain tumor . cancerous tumor removed . remove malignant tumor * *

Related by context. All words. (Click for frequent words.) 74 metastatic lesions 72 metastases 72 tumors 71 lung tumors 70 micrometastases 70 liver metastases 69 leukemic cells 69 melanoma tumors 68 ovarian tumors 68 tumor recurrence 68 lung metastases 68 colorectal tumors 67 renal tumors 67 breast carcinomas 67 GISTs 67 epithelial tumors 67 malignant cells 66 tumor cells 66 GBM tumors 66 renal cell carcinomas 66 neoplastic cells 66 metastatic cancers 66 pancreatic adenocarcinoma 66 carcinoid 66 lymph node metastases 66 CLL cells 66 senescent cells 66 metastatic melanomas 66 mesotheliomas 66 distant metastases 66 metastatic tumor 65 malignant prostate 65 adenocarcinomas 65 N Myc 65 seminomas 65 breast tumors 65 thrombi 65 BRAF mutation 65 metastatic cancer 64 atherosclerotic lesions 64 metastasis 64 tumor metastases 64 metastatic prostate 64 tumor 64 serous ovarian cancer 64 myeloma cells 64 neuroblastoma cells 64 pulmonary metastases 64 mammary cancers 64 glioblastoma cells 64 differentiated thyroid 64 lung nodules 64 peritoneal carcinomatosis 64 tumoral 64 glioblastoma tumor 64 metastatic 64 nonmelanoma skin cancers 63 malignant growths 63 hamartomas 63 noncancerous cells 63 axillary lymph nodes 63 metastatic disease 63 cancerous cells 63 HbF 63 PCa 63 nodal metastasis 63 colon tumors 63 colorectal tumor 63 prostate adenocarcinoma 63 GBMs 63 glioma cells 63 prostate tissue 63 PGE2 63 histopathologic examination 63 neovascularization 63 hypermethylated 63 p# mutation 62 neuroendocrine tumors 62 mucinous 62 premalignant lesions 62 hematopoietic cells 62 precursor lesions 62 basal cell carcinomas 62 GIST tumors 62 cytoreductive surgery 62 malignant tumors 62 osteosarcomas 62 colorectal carcinoma 62 invasive carcinoma 62 Circulating tumor cells 62 cystic lesions 62 hair follicle stem cells 62 metastatic prostate cancer 62 pancreatic cancers 62 histologically 62 metastatic lesion 62 OGG1 62 WT1 62 EGF receptors 62 prostate tumor 62 colorectal adenocarcinoma 62 myocytes 62 cancerous tumors 62 TAp# 62 neuroblastomas 62 contralateral breast 62 BCR ABL mutations 62 amyloid deposits 62 sentinel lymph nodes 62 carcinoid tumors 62 cytotoxic agents 62 gastric cancers 62 advanced adenomas 62 cisplatin resistant 62 bladder cancers 62 diseased tissue 62 trophoblast cells 62 skeletal metastases 62 endocrine tumors 62 malignant lesions 62 grade gliomas 62 glioblastoma tumors 62 urothelial cancer 62 trophoblasts 62 immunized mice 62 hepatocellular carcinoma 62 graft dysfunction 62 cervical lymph nodes 62 angiosarcoma 62 mTOR inhibitors 62 molecular abnormalities 62 lymphoid 62 adenoma 62 cellularity 62 EUS FNA 62 neuroendocrine cancers 61 lobular carcinoma 61 sentinel nodes 61 micrometastasis 61 schwannomas 61 lymph node metastasis 61 benign polyps 61 squamous cell lung cancer 61 hypermethylation 61 bone metastasis 61 node metastases 61 mesothelin 61 pancreatic tumors 61 malignant neoplasm 61 endostatin 61 distant metastasis 61 carcinomas 61 mammary tumors 61 TGF alpha 61 malignancies 61 occult metastases 61 mammary cells 61 lung adenocarcinomas 61 granulocytes 61 epithelial cell 61 glioblastomas 61 lymphatic vessels 61 superficial bladder cancer 61 ADPKD 61 basal cell cancers 61 carcinoid tumor 61 metastatic lymph nodes 61 breast cancer metastasis 61 hepatoma 61 EGFRvIII 61 pancreatic tumor 61 metachronous 61 ependymomas 61 61 pre cancerous growths 61 xenograft tumors 61 liver metastasis 61 CMV disease 61 neural cells 61 Tumor cells 61 explants 61 neoadjuvant therapy 61 malignant transformation 61 oncoprotein 61 colorectal liver metastases 61 Glioblastoma multiforme GBM 61 androgen receptor AR 61 preoperative chemotherapy 61 neoplastic lesions 61 ErbB2 61 carcinoma 61 varices 61 prostate cancer CaP 61 anti apoptotic proteins 61 lung carcinomas 61 Immunohistochemical analysis 61 Lymph nodes 61 EGF receptor 61 squamous 61 hyperplastic 61 microglial activation 60 malignant fibrous histiocytoma 60 neuroblastoma tumors 60 TET2 60 breast carcinoma 60 pulmonary metastasis 60 vestibular schwannomas 60 ductal 60 Glioblastoma multiforme 60 neurofibromas 60 mutant protein 60 neoplasm 60 Metastatic 60 nodal metastases 60 leukemic stem cells 60 mononuclear cells 60 medulloblastomas 60 lung metastasis 60 Tumours 60 coronary vessels 60 uveal melanoma 60 pelvic lymph nodes 60 chemo resistant 60 Malignant tumors 60 tumor biopsies 60 unresectable tumors 60 effector cells 60 pituitary tumors 60 squamous cell carcinoma SCC 60 c MYC 60 lymphoid cells 60 mesenchymal cells 60 Stat5 60 B7 H3 60 Cholangiocarcinoma 60 HER2 positive tumors 60 astrocytomas 60 microglial cells 60 operable breast cancer 60 microvessels 60 leukaemic stem cells 60 castrated mice 60 seminoma 60 benign lesions 60 lytic 60 hematopoietic cell 60 epithelial cancers 60 molecular subtypes 60 meningiomas 60 cholangiocarcinoma 60 Metastases 60 pDCs 60 tNOX 60 prostate cancers 60 VEGF receptor 60 malignancy 60 basal cell nevus syndrome 60 breast cancer subtypes 60 lymph node involvement 60 sarcomatoid 60 p# mutations 60 axillary nodes 60 catheter angiography 60 prostate carcinoma 60 follicular lymphomas 60 pre malignant lesions 60 nasopharyngeal carcinoma 60 adenocarcinoma 60 lymphatic tissue 60 Benign tumors 60 myelomas 60 urothelium 60 infarcts 60 ependymoma 60 autoantibodies 60 hepatocellular carcinomas 60 renal fibrosis 60 breast lesions 60 goblet cells 60 kidney cysts 60 haematopoietic 60 activated microglia 60 osteoclast 60 genetic aberrations 60 calculi 60 MGUS 60 bladder tumors 60 tumor suppressor genes 60 supratentorial 60 lymph vessels 60 anti angiogenic drugs 60 TNFa 60 androgen deprivation 60 Candida infection 60 motoneurons 60 myofibroblasts 60 sentinel lymph node 60 PrPSc 60 orthotopic 60 K ras mutations 60 ductal breast cancer 59 Hepatocellular Carcinoma HCC 59 MDSCs 59 malignant pleural mesothelioma 59 benign tumors 59 intestinal polyps 59 pancreatic carcinoma 59 immunohistochemical staining 59 IGF 1R 59 metastatic neuroendocrine tumors 59 undifferentiated stem cells 59 effector functions 59 TACE 59 esophageal squamous cell carcinoma 59 papillary renal cell carcinoma 59 NF kB pathway 59 basal cell carcinoma BCC 59 VEGF expression 59 leukemic cell 59 premalignant 59 hippocampal neurons 59 plasminogen 59 gliomas 59 EGFr 59 Glioblastoma 59 mutated BRAF gene 59 collagenase 59 ciliated cells 59 mesothelial cells 59 caveolin 1 59 cancerous tissue 59 brain parenchyma 59 diseased tissues 59 carcinoids 59 S. maltophilia 59 lymphatics 59 sporadic ALS 59 gene amplification 59 glomerular 59 synovial sarcoma 59 esophagogastric junction 59 neuroblastoma tumor 59 HER2 receptor 59 lymphoid tissue 59 NKT cells 59 osteochondromas 59 histological subtype 59 paragangliomas 59 NMIBC 59 P selectin 59 cerebral vasospasm 59 FGFR1 59 nonmetastatic 59 Histological examination 59 EGFR mutation 59 pituitary adenomas 59 HNSCC 59 myeloid cells 59 granzyme B 59 epithelial ovarian 59 herpesviruses 59 oncogenes 59 uPAR 59 BMP4 59 renal parenchyma 59 myoblasts 59 lymphangiogenesis 59 recurrent glioblastoma multiforme 59 mutant p# 59 bronchogenic carcinoma 59 metastasise 59 infarct size 59 underarm lymph nodes 59 armpit lymph nodes 59 proto oncogene 59 periodontal bacteria 59 prostate tumors 59 endometrial cells 59 IGFBP 3 59 KRAS mutations 59 suppressor cells 59 C1q 59 medulloblastoma 59 Mitomycin C 59 hepatocellular carcinoma HCC 59 brain metastases 59 solid tumors 59 parenchyma 59 FLT3 59 embryonal rhabdomyosarcoma 59 inhibiting tumor 59 mutant proteins 59 amyloid deposition 59 luminal cells 59 HSCs 59 lobular carcinomas 59 stromal cells 59 leiomyosarcoma 59 renal carcinoma 59 TGF β 59 lesions 59 sCJD 59 cardiac myocytes 59 revascularization procedures 59 intestinal metaplasia 59 invasive ductal 59 cytologically confirmed 59 adenomatous 59 PTEN protein 59 esophageal carcinoma 59 cranial irradiation 59 EGFR mutations 59 E cadherin expression 59 BRAF mutations 59 radiochemotherapy 59 STAT3 59 precancers 59 KIT mutations 59 teratoma 59 TTR gene 59 pro angiogenic 59 BMP signaling 59 E selectin 59 transgene expression 59 EGFR inhibitors 58 incidentalomas 58 neural progenitor cells 58 MAPK pathway 58 sarcosine 58 fibroblast cells 58 gastric adenocarcinoma 58 S. mutans 58 malignant nodules 58 suppressor gene 58 transplanted stem cells 58 Radiofrequency ablation 58 Dpp 58 monocyte chemoattractant protein 58 choroidal neovascularization 58 leukaemic cells 58 Hurthle cell 58 FGFR2 58 pCR 58 epithelial tissues 58 cytoreduction 58 TGF ß1 58 neoplastic 58 fulminant hepatic failure 58 lymph nodes 58 brain lesions 58 leiomyoma 58 chondrocytes 58 GRNOPC1 cells 58 lymph node 58 clinically detectable 58 RGCs 58 cystectomy 58 mRNA expression 58 metastatic lung cancer 58 lymphovascular invasion 58 CD8 T cells 58 Tavocept 58 autoreactive T cells 58 malignant lymphocytes 58 curative resection 58 myogenic 58 NF2 58 Aspergillus infections 58 stem progenitor cells 58 hypoperfusion 58 PECAM 1 58 squamous cell cancers 58 bcl 2 58 infarcted myocardium 58 cutaneous lesions 58 vimentin 58 necrotic core 58 carcinoid cancer 58 Kupffer cells 58 chromosome aberrations 58 histologies 58 glioma tumors 58 somatic mutations 58 cancerous breast 58 dexrazoxane 58 sarcomas 58 leiomyomas 58 lymphoid tissues 58 E#F# 58 EphA2 58 MMP inhibitors 58 cardiac dysfunction 58 papillary RCC 58 endometrial cancers 58 neoadjuvant chemotherapy 58 chemoradiotherapy 58 thymoma 58 cyclin E 58 gadolinium enhanced 58 S#A# [002] 58 Glioma 58 cutaneous melanoma 58 chitinase 58 DNA methylation patterns 58 serine proteases 58 endometrial tissue 58 IDH1 mutations 58 T#I [002] 58 pancreatic islet 58 malignant melanomas 58 vascular endothelial cells 58 HER2 positive cancers 58 MUC1 protein 58 ERBB2 58 CCR7 58 nutlin 3a 58 colonic mucosa 58 metastatic malignant melanoma 58 neoplasms 58 atypical hyperplasia 58 oligodendrogliomas 58 ALK mutations 58 tumor subtypes 58 thymic carcinoma 58 endothelial cell 58 mRNA molecules 58 locoregional 58 Immunosuppressive drugs 58 mutant SOD1 58 neurotrophic 58 splenic 58 antiangiogenic drugs 58 prognostic markers 58 neutrophil 58 RKIP 58 highly vascularized 58 activated lymphocytes 58 MTT assay 58 perfusion defects 58 ZNF# 58 dopaminergic neurons 58 Epstein Barr virus EBV 58 BRAF protein 58 cancerous lesions 58 B Raf 58 malignant tissue 58 liver resection 58 basal cell skin 58 Tumors 58 ocular melanoma 58 serum antibodies 58 colorectal neoplasms 58 renal arteries 58 deacetylase inhibitors 58 percutaneous biopsy 58 leukocyte recruitment 58 tumor stroma 58 metastatic bladder 58 pilocytic astrocytomas 58 Leishmania parasite 58 beta1 integrin 58 colorectal polyp 58 polypoid 58 NOD mice 58 TGF beta pathway 58 epithelia 58 proteoglycan 58 SSc 58 CYT# potent vascular disrupting 58 anaplastic 58 osteoid 58 costimulatory 58 ductal adenocarcinoma 58 mutated K ras 58 interstitium 58 HBV replication 58 osteoclast activity 58 alkaline phosphatase ALP 58 mutated KRAS gene 58 extramedullary 58 endometrial carcinoma 58 remyelination 58 acinar 58 IL 1ß 58 retroperitoneal 58 uPA 58 Sertoli cells 58 radioiodine therapy 58 P. acnes 58 gut mucosa 58 haematopoietic stem cell 58 Lymph node 58 iNOS 58 upregulating 58 EGFR protein 58 Barrett mucosa 58 primary cilia 58 cardiac fibroblasts 58 cancerdefine 58 chromosomal mutations 58 EBV infection 58 immunocompetent 58 pleural mesothelioma 58 immune deficient mice 58 atherosclerotic plaques 58 dopamine neuron 57 KRAS mutation 57 activating mutations 57 resectable 57 histologic subtype 57 paraganglioma 57 pDC 57 somatostatin receptors 57 cancers 57 endometrial hyperplasia 57 innate immune responses 57 variceal 57 β amyloid 57 curable cancers 57 aneuploid cells 57 GPNMB 57 antiproliferative effects 57 thyroglobulin 57 fibrin deposition 57 pre cancerous polyps 57 enzymatic activity 57 nonischemic 57 synovial tissue 57 BRCA deficient 57 transfected cells 57 underwent resection 57 Sentinel node biopsy 57 Notch1 57 CMV infections 57 astrocytoma 57 antitumor immune 57 Ras pathway 57 soluble receptor 57 imatinib Gleevec 57 LRP5 57 Gleevec resistant 57 metaplasia 57 CaM kinase 57 benign nodules 57 lymphocytes 57 parathyroid 57 IGF IR 57 thyroid carcinomas 57 BCL#A 57 systemic amyloidosis 57 peritoneal cancer 57 radical nephrectomy 57 grade cervical intraepithelial 57 papillary 57 sentinel node 57 nonsmall cell lung cancer 57 radiolabeled antibodies 57 Bcl xL 57 hematologic toxicity 57 recurrent prostate cancer 57 Rectal cancer 57 oligodendroglioma 57 miRs 57 MetAP2 57 motor neuron degeneration 57 conventional angiography 57 Cytoxan 57 CMV infection 57 bleomycin 57 apoptotic pathway 57 intracranial hemorrhage ICH 57 castrate resistant 57 radiofrequency ablation RFA 57 BMPR2 57 hyaline cartilage 57 neovascular 57 hepatic metastasis 57 nanomolar 57 normal karyotype 57 Squamous cell carcinomas 57 chemotherapeutic regimens 57 viral antigens 57 genetic alteration 57 chemotherapeutic agents 57 P. gingivalis 57 epithelioid 57 ascites 57 KRAS oncogene 57 enterovirus infection 57 keratinocytes 57 antiangiogenic 57 malignant cancerous 57 papillomas 57 PTEN gene 57 normal prion protein 57 focally 57 atherosclerotic disease 57 p# deficient 57 testicular cancers 57 allogeneic bone marrow 57 osteoblast 57 EZH2 57 HUVEC 57 coronary blockages 57 hematopoietic stem cells 57 metastatic RCC 57 nucleated cells 57 CD8 + 57 Basal cell 57 HER2 overexpression 57 PIK3CA 57 apical membrane 57 polypoid lesions 57 BRAF gene 57 ADPKD patients 57 familial ALS 57 cervical lesions 57 lung adenocarcinoma 57 completely resected 57 prostate cancer PCa 57 sensory axons 57 cell carcinomas 57 hyperalgesia 57 MALT lymphoma 57 insulin secreting cells 57 clonogenic 57 PKCi 57 aP2 57 oncologic outcomes 57 IFN beta 57 Gliomas 57 thoracoscopic lobectomy 57 N. gonorrhoeae 57 extrahepatic 57 EGFR receptor 57 PSADT 57 cerebrospinal fluid CSF 57 VEGFR2 57 HER2 expression 57 squamous cells 57 hepatocytes 57 histone acetylation 57 glioblastoma 57 thyroid nodules 57 oncoproteins 57 lymphoid organs 57 acinar cells 57 Bcr Abl 57 Chronic pancreatitis 57 microglial 57 HSPCs 57 sensory nerve fibers 57 benign moles 57 NAbs 57 pericytes 57 flavopiridol 57 leukocytes 57 ALND 57 SATB1 57 JMML 57 Sjögren syndrome 57 mutated protein 57 telomerase inhibition 57 microRNA miR 57 neuronal stem cells 57 ependymal cells 57 intravenous bisphosphonates 57 oncomodulin 57 mutated KRAS 57 tumor regrowth 57 narrowed carotid arteries 57 IPSCs 57 mediastinum 57 stage IIIA 57 urothelial carcinoma 57 lung fibrosis 57 TP# mutation 57 extracranial 57 lipomas 57 stroma 57 Neural stem cells 57 malignant brain 57 intraoperative complications 57 ALDH br cells 57 precancerous spots 57 axillary node dissection 57 metastatic brain tumor 57 nodular melanoma 57 fibrotic disease 57 subventricular zone 57 microvascular endothelial cells 57 JAK2 enzyme 57 prostate cancer metastases 57 HepG2 cells 57 CIN3 57 breast epithelial cells 57 CGG repeats 57 ovarian carcinoma 57 liposarcoma 57 benign growths 57 prognostic indicator 57 egg follicles 57 MYCN amplification 57 IGFBP2 57 pT3 57 soft tissue sarcomas 57 secretory cells 57 causal variants 57 estrogen receptors 57 CCN2 57 gastric carcinoma 57 ischemic lesions 57 mediated immunity 57 MUC1 * 57 FGFR3 57 PC3 cells 57 androgen receptor signaling 57 FGFR4 57 Akt1 57 SOD1 57 ductal carcinomas 57 adenomatous polyp 57 circulating lymphocytes 57 ERK1 2 57 molecularly targeted 57 prostate carcinomas 57 ADAMTS# 57 ERK2 57 BRAF V#E mutation 57 MDM2 57 nestin 57 K#R [002] 57 colorectal adenoma 57 epidermal cells 57 PNET 57 TGF beta signaling 57 p# activation 57 pancreatectomy 57 NF kappaB activation 57 BCR ABL 57 tumor vasculature 57 biochemical recurrence 57 cell lysis 57 grade glioma 57 synovial cells 56 pleomorphic 56 proliferative diabetic retinopathy 56 granulocyte 56 Th1 cells 56 TGF b 56 cell carcinoma 56 biochemical relapse 56 membranous nephropathy 56 familial pancreatic cancer 56 EGFR pathway 56 IGFBP 56 spinal metastases 56 misfolded SOD1 56 tumor xenograft models 56 Cancerous cells 56 basal cell cancer 56 tumor nodules 56 allogeneic transplants 56 HER2 gene 56 hematopoetic stem cells 56 beta catenin protein 56 coronary stenoses 56 TH# cells 56 melanoma lesions 56 S. pyogenes 56 TGF ß 56 tenascin C 56 locoregional recurrence 56 p#NTR 56 HLA DR 56 macrophage cells 56 mesenteric 56 clusterin 56 interleukins 56 hepatectomy 56 cardiac progenitor cells 56 integrins 56 Notch receptors 56 cytotoxin 56 IDH mutations 56 ABCB1 56 neuro degenerative disease 56 immunohistochemical 56 luminal 56 meningeal 56 PNH patients 56 aneuploidies 56 Vidofludimus 56 systemic toxicity 56 resected 56 Metastatic colorectal cancer 56 cell signaling pathways 56 pRb 56 cranial radiation 56 low expressors 56 prophylactic cranial irradiation 56 hyperoxaluria 56 GNAQ 56 Acoustic neuromas 56 pancreatic endocrine 56 haematopoietic stem cells 56 AGTR1 56 Fibroblasts 56 EpCAM 56 submucosa 56 HDACs 56 CIN2 + 56 cervical neoplasia 56 chemoresistant 56 primordia 56 fibrotic tissue 56 fibroadenoma 56 vWF 56 cypin 56 noncalcified 56 HCV replication 56 IL 1beta 56 Histologically 56 Bone marrow stem cells 56 paricalcitol 56 Her2/neu 56 trastuzumab resistant 56 sentinel lymph node biopsy 56 fibrocytes 56 mutant worms 56 neural tissues 56 mammary duct 56 calcineurin 56 transplanted bone marrow 56 carotid plaque 56 chemoresistance 56 MT1 MMP 56 pelvic lymphadenectomy 56 endometrial 56 Li Fraumeni 56 cisplatin chemotherapy 56 tumor excision 56 neutrophils 56 transthyretin 56 HG PIN 56 amyloid plaque 56 PlGF 56 cytotoxic therapies 56 choroidal melanoma 56 thyroid nodule 56 Notch signaling 56 axillary dissection 56 tumor necrosis 56 axillary lymph node dissection 56 mouse testes 56 antiangiogenic therapy 56 thyroid carcinoma 56 synovium 56 GRK2 56 hematologic disorders 56 malignant lymphoma 56 neurotrophins 56 Recurrences 56 basal cells 56 transmembrane protein 56 A. fumigatus 56 periodontal pathogens 56 mitomycin C 56 bacterial colonization 56 nucleolin 56 leukaemias 56 MSH2 56 tumorous cells 56 thrombotic complications 56 anti angiogenic agents 56 actinic keratoses 56 axillary node 56 Carcinoid tumors 56 Th2 cytokines 56 gastrointestinal GI cancers 56 lymphocytosis 56 HDAC6 56 neoplasia 56 HSV1 56 sirolimus 56 cAMP signaling 56 HER2 receptors 56 Foxp3 56 Prox1 56 colorectal carcinomas 56 biliary tree 56 obstructive coronary artery 56 tyrosine kinase inhibitors 56 ncRNAs 56 osteoblastic 56 osteogenic differentiation 56 antibody mediated 56 eIF 4E 56 intraductal

Back to home page